I don't think there is any way the results of a larger trial will be better than interim data (that bar is crazy high). All we need is a statistically meaningful difference from the placebo arm. That will mean success and a bright future for the company.
The good news is that we're probably less than a week away from getting the data.
News 
Market Data 
Discover 
